HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients

No data are available on the role of HER2 overexpression in predicting the efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients. We retrospectively evaluated this role in patients enrolled in a phase III study comparing standard FEC21 (5-fluorouracil, epiru...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Del Mastro, L, Bruzzi, P, Nicolò, G, Cavazzini, G, Contu, A, D'Amico, M, Lavarello, A, Testore, F, Castagneto, B, Aitini, E, Perdelli, L, Bighin, C, Rosso, R, Venturini, Marco
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2005
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361477/
https://ncbi.nlm.nih.gov/pubmed/15970926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602660
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars